Vivos Therapeutics, Inc.
VVOS
Rank in Stocks
#32660
Vivos Therapeutics, Inc. operates as a medical technology company that develops... Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Share Price
$0.0958
Last synced: 2026-11-09
Market Cap
$1.33M
Change (1 day)
2.24%
Change (1 year)
-96.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vivos Therapeutics, Inc. (VVOS)
Category
Healthcare
EPS for Vivos Therapeutics, Inc. (VVOS)
EPS as of June 2026 TTM: $-2.06
According to Vivos Therapeutics, Inc.'s latest financial reports, its current EPS (TTM) is $-2.06. At the end of 2025 the company had an EPS of $-2.06, an increase over its 2024 EPS of $-2.22.
EPS history for Vivos Therapeutics, Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-2.06 | 0.00% |
| 2025 | $-2.06 | -7.21% |
| 2024 | $-2.22 | -80.07% |
| 2023 | $-11.14 | -56.99% |
| 2022 | $-25.90 | 8.41% |
| 2021 | $-23.89 | -3.28% |
| 2020 | $-24.70 | 12.58% |
| 2019 | $-21.94 | 18.66% |
| 2018 | $-18.49 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -231.07% |
US
|
|
| $4.09 | -298.54% |
IE
|
|
| $9.45 | -558.74% |
US
|
|
| $2.37 | -215.05% |
US
|
|
| $1.77 | -185.92% |
US
|
Questions about Vivos Therapeutics, Inc.'s earnings per share (EPS)
What is Vivos Therapeutics, Inc.'s earnings per share (EPS)?
Vivos Therapeutics, Inc.'s earnings per share (EPS) over the last twelve months is $-2.06, as of Jun 2026.
What was Vivos Therapeutics, Inc.'s earnings per share (EPS) in 2025?
In 2025, Vivos Therapeutics, Inc.'s earnings per share (EPS) was $-2.06, compared with $-2.22 in 2024.
How has Vivos Therapeutics, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Vivos Therapeutics, Inc.'s earnings per share (EPS) was highest in 2025 ($-2.06) and lowest in 2022 ($-25.90).
How does Vivos Therapeutics, Inc.'s earnings per share (EPS) compare with similar companies?
Vivos Therapeutics, Inc.'s earnings per share (EPS) ($-2.06) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.